Μηνύματα από τις σπουδαιότερες μελέτες στην ηλεκτροφυσιολογία το διάστημα

Size: px
Start display at page:

Download "Μηνύματα από τις σπουδαιότερες μελέτες στην ηλεκτροφυσιολογία το διάστημα"

Transcription

1 Μηνύματα από τις σπουδαιότερες μελέτες στην ηλεκτροφυσιολογία το διάστημα Δημήτριος M. Κωνσταντίνου Ειδικός Καρδιολόγος, MD, MSc, PhD, CCDS Πανεπιστημιακός Υπότροφος

2 Dr. Konstantinou has received grants from Medtronic

3 Presentation outline Paroxysmal AF Cryoballoon vs. RF ablation of pulmonary veins -Freeze-AF, FIRE AND ICE Contact Force sensing vs. standard RF ablation catheters -TOCCASTAR, EFFICAS II Persistent AF Pulmonary vein isolation vs. additional substrate modification -STAR-AF Silent AF Implantable Loop Recorders vs. conventional ECG monitoring techniques -CRYSTAL-AF

4 Presentation outline (cont.) Pharmacotherapy for paroxysmal AF Low dose dronedarone + moderate dose ralonazine -The Harmony Trial Improving CRT response rates Emerging CRT algorithms -AdaptivCRT Multipoint Pacing -IRON-MPP registry Primary prevention of sudden cardiac death The role of prophylactic ICD implantation in DCM -DANISH trial

5 Cryoballoon vs. Radiofrequency ablation of pulmonary veins

6 N Engl J Med 2016;374:

7 Primary efficacy endpoint: 1. recurrence of AF (lasting >30 s), 2. occurrence of Afl/AT, 3. prescription of class I/III AADs or 4. repeat ablation N Engl J Med 2016;374:

8 treatment of patients with drug-refractory paroxysmal AF, PV isolation by means of CB ablation was non-inferior to RF ablation in terms of efficacy and safety. N Engl J Med 2016;374:

9 Contact force-sensing ablation catheter vs. standard, non-force-sensing catheter

10 Circulation. 2015;132:907-15

11 CF-sensing ablation catheter was non-inferior to the standard non force-sensing catheter with respect to shortand long-term efficacy and safety. The use of optimal CF (>10 g) was associated with higher success. Circulation. 2015;132:907-15

12 Contact Force (CF) guidelines: 1. target CF of 20 g (range g) AND 2. minimum Force-Time Integral of 400 gs Continuity Index (CI) assessment* *no guidance on CI was given to operators Europace 2015;17:

13 Conduction gaps were assessed by remapping of PVs after 3 months Europace 2015;17:

14 In EFFICAS II, PV lines isolated initially with a CI<6 (low CI) had a 98% chance of remaining isolated.

15 Pulmonary vein isolation vs. additional substrate modification in persistent AF

16 N Engl J Med 2015;372:

17 Among patients with persistent AF, we found no reduction in the rate of recurrent AF when either linear ablation or ablation of complex fractionated electrograms was performed in addition to pulmonary-vein isolation. More extensive ablation may cause new, iatrogenic areas of arrhythmogenesis where tissue is incompletely ablated or linear block is not achieved. Perhaps neither complex electrograms nor lines are the correct supplemental targets for ablation N Engl J Med 2015;372:

18 Facts: 1. Up to 40% of ischemic strokes initially classified as cryptogenic 2. Silent AF is present in 30% of cryptogenic stroke patients 3. Standard 24-hour Holter monitoring limited sensitivity for the detection of new AF (2%-6%) Circ Arrhythm Electrophysiol. 2016;9:e003333

19 Implantable Loop Recorders

20 In conclusion, extended long-term monitoring with an ICM uncovered AF in a high proportion of patients with prior CS or TIA. Detection of AF resulted in OAC therapy prescription in the majority of patients. Circ Arrhythm Electrophysiol. 2016;9:e003333

21 All patients had a DDD pacemaker implanted for standard clinical indications before enrollment All devices had atrial arrhythmia detection algorithms+egm storing capacity Circ Arrhythm Electrophysiol. 2015;8:

22 Combining 2 drugs with complementary electrophysiological properties (increased efficacy) at lower doses (decreased toxicity) Multi-channel blockade Contraindicated in HF due to negative inotropism from block of L-type Ca ++ channels (concentration dependent) Lower doses should be less cardio-depressant Late Na + current inhibition decreases cellular Na + & Ca ++ loading thereby EAD and DAD occurrence

23 moderate dose ranolazine combined with reduced dose dronedarone can decrease AF yet maintain good tolerance/safety in the population enrolled. Circ Arrhythm Electrophysiol. 2015;8:

24 THERE ARE OPPORTUNITIES TO IMPROVE CRT RESPONSE POTENTIAL REASONS FOR SUBOPTIMAL CRT RESPONSE 1 1 Mullens W, et al. J Am Coll Cardiol. 2009;53: Claria MRI Quad SureScan CRT-D Customer Presentation

25 ADAPTIVCRT ALGORITHM OPERATION LV pacing can be at least as efficacious as BiV pacing In patients with SR and normal AV conduction, pacing only the LV with appropriate AV intervals can result in even superior LV and RV function compared with standard BiV pacing The algorithm is intended to provide ambulatory CRT optimization, allow more physiologic ventricular activation and greater device longevity in patients with normal AV conduction by reducing unnecessary RV pacing 25 Claria MRI Quad SureScan CRT-D Customer Presentation

26 Heart Rhythm 2012;9:

27 43.8% absolute reduction in RV pacing The acrt algorithm was safe and at least as effective as BiV pacing with comprehensive echocardiographic optimization across a variety of endpoints. Heart Rhythm 2012;9:

28 % patient improved in Clinical Composite Score ADAPTIVCRT IMPROVES PATIENT OUTCOMES BY Improving CRT Response by 12% 1 For patients in sinus rhythm, with normal AV conduction and LBBB 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 81% p = % Normal AV AdaptivCRT Echo-optimised CRT AdaptivCRT: Produced mostly synchronized LV pacing (73% +/- 25%) Resulted in better clinical response at 6 months (81% vs. 69%) 1 Birnie D, et al. Heart Rhythm. 2013;10: Claria MRI Quad SureScan CRT-D Customer Presentation

29 ADAPTIVCRT IMPROVES PATIENT OUTCOMES BY Providing a 46% reduction in AF risk *1 For all patients * Compared to echo-optimized BiV pacing. 1 Martin D, et al. Clinical Outcomes with Adaptive Cardiac Resynchronization Therapy: Long-term Outcomes of the Adaptive CRT Trial. HFSA Late Breakers. September 23, Claria MRI Quad SureScan CRT-D Customer Presentation

30 ADAPTIVCRT IMPROVES PATIENT OUTCOMES BY Reducing a patient s odds of a 30-Day HF Readmission * by 59% 1 For all patients * Readmissions following an HF hospitalization. 1 Starling RC, Krum H, Bril S, et al. Impact of a Novel Adaptive Optimization Algorithm on 30- Day Readmissions: Evidence From the Adaptive CRT Trial. JACC Heart Fail. July 2015;3(7): Claria MRI Quad SureScan CRT-D Customer Presentation

31 THERE ARE OPPORTUNITIES TO IMPROVE CRT RESPONSE POTENTIAL REASONS FOR SUBOPTIMAL CRT RESPONSE 1 1 Mullens W, et al. J Am Coll Cardiol. 2009;53: Claria MRI Quad SureScan CRT-D Customer Presentation

32 MULTIPLE POINT PACING OPTION TO IMPROVE CRT RESPONSE IN SOME NON-RESPONDERS Multiple Point Pacing allows to pace from 2 LV electrodes instead of one. Potential benefits of Multiple Point Pacing: Capture a larger area of the LV Engage areas around scar tissue Improve pattern of de/repolarization Improve acute/chronic hemodynamics Improve resynchronization Several small studies have been shown that Multiple Point Pacing is safe 2,3 and resulted in similar or better acute hemodynamics 4-8 and better chronic outcomes 5 versus standard BiV pacing. Multiple Point Pacing may benefit non-responders compared to standard CRT Claria MRI Quad SureScan CRT-D Customer Presentation

33 Compared with conventional CRT, MPP resulted in an additional increase in ejection fraction and clinical composite response. Europace 2016 doi: /europace/euw094

34 How to choose the optimal vector/timing? Europace 2016 doi: /europace/euw094

35 The results revealed different practices among centers, and establishing the optimal programming in order to maximize the benefit of MPP remains a challenging issue. Europace 2016 doi: /europace/euw094

36 DOI: /NEJMoa

37 All time-to-event curves appeared to diverge during the initial 5 years of the trial and then to converge DOI: /NEJMoa

38 31% of deaths due to noncardiovascular causes DOI: /NEJMoa

39 Patients with nonischemic HF may be less prone to death from arrhythmia than patients with ischemic HF better medical treatment and CRT also may have reduced the risk of death from arrhythmia for all patients with HF. At present, it is therefore unclear whether patients who are eligible for CRT should routinely receive an ICD. the benefit of ICD implantation with respect to sudden cardiac death is convincing, and patients who are not expected to die from other causes may be good candidates for ICD implantation. DOI: /NEJMoa

40 Take Home Messages In paroxysmal AF, PV isolation by means of CB ablation is non-inferior to RF ablation in terms of efficacy and safety -shorter procedural time, steeper learning curve -longer fluoroscopy time, more phrenic nerve palsy (usually resolves spontaneously) In paroxysmal AF, CF-sensing ablation catheter is non-inferior to the standard non force-sensing catheter with respect to short- and longterm efficacy and safety -incorporating CF guidelines (i.e. CF of 20g AND min FTI of 400gs) and aiming for contiguous lesion formation (low continuity index<6), initial PV lines have a 98% chance of remaining isolated after 3 months

41 Take Home Messages In persistent AF, adding linear ablation or ablation of complex fractionated electrograms to standard pulmonary-vein isolation did not reduce the rate of recurrent AF In patients with prior CS or TIA, extended long-term monitoring with an ICM uncovered AF almost 9 times more often compared to conventional monitoring which resulted in OAC therapy prescription in the majority of cases Moderate dose ranolazine combined with reduced dose dronedarone can decrease AF yet maintain good tolerance/safety

42 Take Home Messages The acrt algorithm was safe and at least as effective as BiV pacing with comprehensive echocardiographic optimization -Superior clinical outcomes may be expected in patients with SR, normal AV conduction and LBBB Compared with conventional CRT, MPP resulted in an additional increase in ejection fraction and clinical composite response -establishing the optimal programming in order to maximize the benefit of MPP remains a challenging issue Prophylactic ICD implantation in symptomatic DCM patients did not reduce long-term mortality but -it did halve the risk for sudden cardiac death overall -it did reduce all cause mortality in younger patients

43 Ευχαριστώ πολύ για την προσοχή σας!

Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες

Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες Δημήτριος M. Κωνσταντίνου Ειδικός Καρδιολόγος, MD, MSc, PhD, CCDS Πανεπιστημιακός Υπότροφος Dr. Konstantinou

More information

ECG in CRT patients & novel HF therapies. Δημήτριος M. Κωνσταντίνου Ειδικός Καρδιολόγος, MD, MSc, PhD, CCDS Πανεπιστημιακός Υπότροφος

ECG in CRT patients & novel HF therapies. Δημήτριος M. Κωνσταντίνου Ειδικός Καρδιολόγος, MD, MSc, PhD, CCDS Πανεπιστημιακός Υπότροφος ECG in CRT patients & novel HF therapies Δημήτριος M. Κωνσταντίνου Ειδικός Καρδιολόγος, MD, MSc, PhD, CCDS Πανεπιστημιακός Υπότροφος Dr. Konstantinou has received grants from Medtronic Is identification

More information

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh Arrhythmias and Heart Failure Ventricular Supraventricular VT/VF Primary prevention

More information

Implantable Cardiac Monitors for Atrial Fibrillation (AF) Detection: Ready for Routine Use?

Implantable Cardiac Monitors for Atrial Fibrillation (AF) Detection: Ready for Routine Use? Implantable Cardiac Monitors for Atrial Fibrillation (AF) Detection: Ready for Routine Use? Helmut Pürerfellner, MD, Assoc. Prof. Saint Elisabeth s Sisters Hospital Academic Teaching Center Linz/Austria

More information

What s new in my specialty?

What s new in my specialty? What s new in my specialty? Jon Melman, MD Heart Rhythm Specialists McKay-Dee Hospital some would say some would say my specialty 1 some would say my specialty First pacemaker 1958 some would say my specialty

More information

This is What I do to Improve CRT Response for CRT Non-Responders

This is What I do to Improve CRT Response for CRT Non-Responders This is What I do to Improve CRT Response for CRT Non-Responders Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC Disclosures: Steering Committees (unpaid) and Clinical Trials,

More information

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology Atrial Fibrillation: Rate vs. Rhythm Michael Curley, MD Cardiac Electrophysiology I have no relevant financial disclosures pertaining to this topic. A Fib Epidemiology #1 Most common heart rhythm disturbance

More information

Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes

Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes Francis Marchlinski, MD Richard T and Angela Clark President s Distinguished Professor Director Cardiac Electrophysiolgy University

More information

Interventional solutions for atrial fibrillation in patients with heart failure

Interventional solutions for atrial fibrillation in patients with heart failure Interventional solutions for atrial fibrillation in patients with heart failure Advances in Cardiovascular Arrhythmias Great Innovations in Cardiology Matteo Anselmino, MD PhD Division of Cardiology Department

More information

14ο Βορειοελλαδικό Καρδιολογικό Συνέδριο ΚΕΒΕ Βηματοδότηση: Νεότερες εξελίξεις Προοπτικές

14ο Βορειοελλαδικό Καρδιολογικό Συνέδριο ΚΕΒΕ Βηματοδότηση: Νεότερες εξελίξεις Προοπτικές 14ο Βορειοελλαδικό Καρδιολογικό Συνέδριο ΚΕΒΕ Βηματοδότηση: Νεότερες εξελίξεις Προοπτικές Α.Γ. Κατσίβας Συντονιστής Διευθυντής, Α Καρδιολογική Κλινική, ΓΝΑ «Κοργιαλένειο-Μπενάκειο Ε.Ε.Σ» BRADY - ARRHYTHMIA

More information

A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC

A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC AF Clinical/Referral Challenge Asymptomatic 40% 3 Rx Effective 30% Failed Rx Ablation Atrial fibrillation (AF) is the most common Candidate

More information

Θα πρέπει να αναζηηείηαι η παροσζία ζιωπηλής κολπικής μαρμαρσγή ζε αζθενείς με κρσπηογενές εγκεθαλικό επειζόδιο; Ποιά είναι η καλύηερη μέθοδος;

Θα πρέπει να αναζηηείηαι η παροσζία ζιωπηλής κολπικής μαρμαρσγή ζε αζθενείς με κρσπηογενές εγκεθαλικό επειζόδιο; Ποιά είναι η καλύηερη μέθοδος; Θα πρέπει να αναζηηείηαι η παροσζία ζιωπηλής κολπικής μαρμαρσγή ζε αζθενείς με κρσπηογενές εγκεθαλικό επειζόδιο; Ποιά είναι η καλύηερη μέθοδος; Νικόλαος Φραγκάκης Λέκηορας Καρδιολογίας, FESC Ιπποκράηειο

More information

Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.

Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ» Rhythm control antiarrhythmic drugs vs catheter ablation Summary

More information

How do I convert my CRT Non Responder into Responder?

How do I convert my CRT Non Responder into Responder? How do I convert my CRT Non Responder into Responder? Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC Disclosures: Clinical Trials and Consulting Boston Scientific, Medtronic

More information

Combined catheter ablation and left atrial appendage closure as a. treatment of atrial fibrillation

Combined catheter ablation and left atrial appendage closure as a. treatment of atrial fibrillation Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation Giulio Molon, MD FACC, FESC, Fellow ANMCO Card Dept, S.Cuore hospital Negrar

More information

First question: Does CRT Work in AF?

First question: Does CRT Work in AF? CRT in AF Does it work and when to ablate AF versus AV node Maurizio Gasparini Chief EP and Pacing Unit Humanitas Research Hospital, Rozzano - Milano, Italy First question: Does CRT Work in AF? As any

More information

EBR Systems, Inc. 686 W. Maude Ave., Suite 102 Sunnyvale, CA USA

EBR Systems, Inc. 686 W. Maude Ave., Suite 102 Sunnyvale, CA USA Over 200,000 patients worldwide are estimated to receive a CRT device each year. However, limitations prevent some patients from benefiting. CHALLENGING PROCEDURE 5% implanted patients fail to have coronary

More information

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco Matteo Anselmino Division of Cardiology Città della Salute e della Scienza Hospital University of Turin, Italy Disclosure: Honoraria

More information

Outcomes of AF Ablation

Outcomes of AF Ablation 2017 춘계심혈관통합학술대회 AF Summit: Atrial Fibrillation Apr.21(Fri) 14:40-16:10 Rm.300B 15:00-15:10 Outcomes of AF Ablation Gi-Byoung Nam MD Asan Medical Center, UUCM 2017 Annual Spring Scientific Conference of

More information

Devices and Other Non- Pharmacologic Therapy in CHF. Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine

Devices and Other Non- Pharmacologic Therapy in CHF. Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine Devices and Other Non- Pharmacologic Therapy in CHF Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine Disclosure None University of Miami vs. OSU Renegade Miami football

More information

Cardiac Imaging in abnormal rhythm Role of MDCT

Cardiac Imaging in abnormal rhythm Role of MDCT Cardiac Imaging in abnormal rhythm Role of MDCT Cardiac Imaging in abnormal rhythm Role of MDCT Scope of the problem CT in Atrial Fibrillation CT and pacing Ventricular arrhythmia Other applications 1

More information

Rebuttal. Jerónimo Farré MD 2010

Rebuttal. Jerónimo Farré MD 2010 Rebuttal 1.We do not know what are the types of AF in which ablation is worthless or most effective 2.Waiting implies to consider the ablation at an older age and when the duration of the history of AF

More information

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro Jerónimo Farré MD, Madrid, ES AF: the kingdom of wishful thinking In AF we

More information

Multisite Left Ventricular Pacing for Cardiac Resynchronization

Multisite Left Ventricular Pacing for Cardiac Resynchronization Multisite Left Ventricular Pacing for Cardiac Resynchronization C. W. Israel, M.D. Ass. Prof. Dept. of Medicine Cardiology Evangelical Hospital Bielefeld Germany J. W. Goethe University Frankfurt C.W.Israel@em.uni-frankfurt.de

More information

A Square Peg in a Round Hole: CRT IN PAEDIATRICS AND CONGENITAL HEART DISEASE

A Square Peg in a Round Hole: CRT IN PAEDIATRICS AND CONGENITAL HEART DISEASE A Square Peg in a Round Hole: CRT IN PAEDIATRICS AND CONGENITAL HEART DISEASE Adele Greyling Dora Nginza Hospital, Port Elizabeth SA Heart November 2017 What are the guidelines based on? MADIT-II Size:

More information

Large RCT s of CRT 2002 to present

Large RCT s of CRT 2002 to present Have We Expanded Our Use of CRT for Heart Failure Patients? Sana M. Al-Khatib, MD, MHS Associate Professor of Medicine Electrophysiology Section- Division of Cardiology Duke University Potential Conflicts

More information

ESC Stockholm Arrhythmias & pacing

ESC Stockholm Arrhythmias & pacing ESC Stockholm 2010 Take Home Messages for Practitioners Arrhythmias & pacing Prof. Panos E. Vardas Professor of Cardiology Heraklion University Hospital Crete, Greece Disclosures Small teaching fees from

More information

Atrial Fibrillation Ablation in Patients with Heart Failure

Atrial Fibrillation Ablation in Patients with Heart Failure Atrial Fibrillation Ablation in Patients with Heart Failure Eleftherios M. Kallergis, MD, PhD, FESC Cardiology Department, Heraklion University Hospital Since auricular fibrillation so often complicates

More information

Rate and Rhythm Control of Atrial Fibrillation

Rate and Rhythm Control of Atrial Fibrillation Rate and Rhythm Control of Atrial Fibrillation April 21, 2017 춘계심혈관통합학술대회 Jaemin Shim, MD, PhD Arrhythmia Center Korea University Anam Hospital Treatment of AF Goal Reducing symptoms Preventing complication

More information

Treatment of AF by Pacing Therapy Is there Anything Else Beyond AVN Ablation?

Treatment of AF by Pacing Therapy Is there Anything Else Beyond AVN Ablation? 1 Treatment of AF by Pacing Therapy Is there Anything Else Beyond AVN Ablation? Chu-Pak Lau, MD Honorary Clinical Professor Queen Mary Hospital The University of Hong Kong How to Prevent AF by Pacing 1.

More information

Catheter ablation in AF patients with heart failure. What is possible?

Catheter ablation in AF patients with heart failure. What is possible? Catheter ablation in AF patients with heart failure What is possible? Sébastien Knecht, MD PhD Hôpital cardiologique du Haut L Evêque, Bordeaux HEART FAILURE AND AF Ehrlich. JCE 2002 (13): 399-405, Wang

More information

Atrial Fibrillation Ablation in Patients with Heart Failure

Atrial Fibrillation Ablation in Patients with Heart Failure Atrial Fibrillation Ablation in Patients with Heart Failure Eleftherios M. Kallergis, MD, PhD, FESC Cardiology Department, Heraklion University Hospital Since auricular fibrillation so often complicates

More information

Ενδείξεις αμφικοιλιακής βηματοδότησης. Ποιοι ασθενείς με καρδιακή ανεπάρκεια πρέπει να λάβουν αμφικοιλιακό απινιδωτή;

Ενδείξεις αμφικοιλιακής βηματοδότησης. Ποιοι ασθενείς με καρδιακή ανεπάρκεια πρέπει να λάβουν αμφικοιλιακό απινιδωτή; Ενδείξεις αμφικοιλιακής βηματοδότησης. Ποιοι ασθενείς με καρδιακή ανεπάρκεια πρέπει να λάβουν αμφικοιλιακό απινιδωτή; Άννα Κωστοπούλου Επιμελήτρια Α Ωνάσειο Καρδιοχειρουργικό Κέντρο Τμήμα Ηλεκτροφυσιολογίας

More information

Catheter Ablation of Atrial Fibrillation Strategy and Outcome Predictors Shih-Ann Chen MD

Catheter Ablation of Atrial Fibrillation Strategy and Outcome Predictors Shih-Ann Chen MD Catheter Ablation of Atrial Fibrillation Strategy and Outcome Predictors Shih-Ann Chen MD Taipei Veterans General Hospital, Taiwan Outline of AF Ablation 1. Strategy for Catheter Ablation of AF 2. Substrate

More information

Fibrillazione atriale e scompenso: come interrompere il circolo vizioso.

Fibrillazione atriale e scompenso: come interrompere il circolo vizioso. Alessandria, September 23 th 2017 Fibrillazione atriale e scompenso: come interrompere il circolo vizioso. Professor Fiorenzo Gaita Chief of the Cardiovascular Department Città della Salute e della Scienza

More information

Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy

Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Evan Adelstein, MD, FHRS John Gorcsan III, MD Samir Saba, MD, FHRS

More information

עדכונים באלקטרופיזיולוגיה Electrophysiology Unit Soroka University Medical Center Faculty of Health Sciences Ben-Gurion University of the Negev

עדכונים באלקטרופיזיולוגיה Electrophysiology Unit Soroka University Medical Center Faculty of Health Sciences Ben-Gurion University of the Negev עדכונים באלקטרופיזיולוגיה 2014 Electrophysiology Unit Soroka University Medical Center Faculty of Health Sciences Ben-Gurion University of the Negev 1 מבנה הצגת היחידה פעילות ביחידה סקירה על הטיפול באלקטרופיזיולוגיה

More information

AF and arrhythmia management. Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire

AF and arrhythmia management. Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire AF and arrhythmia management Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire Atrial fibrillation Paroxysmal AF recurrent AF (>2 episodes) that

More information

Atrial Fibrillation New Approaches, Techniques, and Technology

Atrial Fibrillation New Approaches, Techniques, and Technology New Cardiovascular Horizons 2015 May 28, 2015 New Orleans, Louisiana Atrial Fibrillation New Approaches, Techniques, and Technology State of the Art - - 2015 Richard Abben, M D Director, Cardiac Arrhythmia

More information

علم االنسان ما لم يعلم

علم االنسان ما لم يعلم In the name of Allah, the Beneficiate, the Merciful ق ال هللا تعالي: 5 الدى علم بالق لم 4 علم االنسان ما لم يعلم سورة العلق It is He (Allah), Who has taught by the pen He has taught man which he did not

More information

Cardiac Resynchronisation Therapy for all Patients Requiring Ventricular Pacing

Cardiac Resynchronisation Therapy for all Patients Requiring Ventricular Pacing Cardiac Resynchronisation Therapy for all Patients Requiring Ventricular Pacing Philippe Mabo University Hospital, Rennes, France ESC Congress 2010, Stockholm 29 Aug 2010 Which Patients? Candidate for

More information

3/25/2017. Program Outline. Classification of Atrial Fibrillation

3/25/2017. Program Outline. Classification of Atrial Fibrillation Alternate Strategies to Antiarrhythmic Therapy: The Role of Ablation Jennifer El Aile, MS, AGPCNP-BC Electrophysiology Nurse Practitioner Clinical Lecturer at the University of Michigan Program Outline

More information

AF ABLATION Concepts and Techniques

AF ABLATION Concepts and Techniques AF ABLATION Concepts and Techniques Antony F Chu, M.D. Director of Complex Ablation Arrhythmia Services Section Division of Cardiology at the Rhode Island and Miriam Hospital HIGHLIGHTS The main indications

More information

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Colette Seifer MB(Hons) FRCP(UK) Associate Professor, University of Manitoba, Cardiologist, Cardiac Sciences Program, St Boniface Hospital

More information

Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation

Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation 48 th Annual New York Cardiovascular Symposium Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation Is Left Atrial Appendage Dysfunction Sufficient to Generate Clots? December

More information

Role of LAA isolation in AF cure

Role of LAA isolation in AF cure MAM 2017, Zurich Role of LAA isolation in AF cure Sakis Themistoclakis, MD Director, Unit of Electrophysiology and Cardiac Pacing Department of Cardiothoracic & Vascular Medicine Ospedale dell Angelo,

More information

Atrial Fibrillation and Heart Failure: Rate vs. Rhythm Control Time for Re-evaluation

Atrial Fibrillation and Heart Failure: Rate vs. Rhythm Control Time for Re-evaluation Atrial Fibrillation and Heart Failure: Rate vs. Rhythm Control Time for Re-evaluation ANIL K. BHANDARI, M.D, Director, Electrophysiology and EPS Fellowship Program Good Samaritan Hospital/ Harbor UCLA

More information

Bi-Ventricular pacing after the most recent studies

Bi-Ventricular pacing after the most recent studies Seminars of the Hellenic Working Groups February 18th-20 20,, 2010, Thessaloniki, Greece Bi-Ventricular pacing after the most recent studies Maurizio Lunati MD Director EP Lab & Unit Cardiology Dpt. Niguarda

More information

Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method. Konstantinos P.

Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method. Konstantinos P. Ioannina 2015 Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method Konstantinos P. Letsas, MD, FESC SECOND DEPARTMENT OF CARDIOLOGY LABORATORY

More information

Atrial fibrillation: why it's important to make opportunities diagnosis in single chamber ICD patients

Atrial fibrillation: why it's important to make opportunities diagnosis in single chamber ICD patients ADVANCES IN CARDIAC ARRHYTHMIAS and GREAT INNOVATIONS IN CARDIOLOGY Turin October 13-15, 2016 Atrial fibrillation: why it's important to make opportunities diagnosis in single chamber ICD patients Dott.

More information

Technical Considerations Prior to CRT Implant: Quadripolar LV Lead, Adaptive CRT and Something Else? 2015 Update

Technical Considerations Prior to CRT Implant: Quadripolar LV Lead, Adaptive CRT and Something Else? 2015 Update Technical Considerations Prior to CRT Implant: Quadripolar LV Lead, Adaptive CRT and Something Else? 2015 Update ALAN CHENG, MD ASSOCIATE PROFESSOR OF MEDICINE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE

More information

Abstract nr. 1 Abstract code Hybrid Versus Catheter Ablation for Atrial Fibrillation: the HARTCAP-AF Trial

Abstract nr. 1 Abstract code Hybrid Versus Catheter Ablation for Atrial Fibrillation: the HARTCAP-AF Trial Abstract nr. 1 Hybrid Versus Catheter Ablation for Atrial Fibrillation: the HARTCAP-AF Trial Auteur Vroomen, M., Maastricht University Medical Center, Maastricht, Nederland Co-auteur(s) - La Meir, M. Co-auteur(s)

More information

Device detected AF and atrial high rate episodes

Device detected AF and atrial high rate episodes Device detected AF and atrial high rate episodes Professor Paulus Kirchhof University of Birmingham Institute of Cardiovascular Sciences SWBH and UHB NHS trusts, Birmingham, UK Department of Cardiovascular

More information

INNOVATIONS IN DEVICE THERAPY:

INNOVATIONS IN DEVICE THERAPY: INNOVATIONS IN DEVICE THERAPY: Subcutaneous ICDs, Leadless Pacemakers, CRT Indications David J Wilber MD Loyola University Medical Center Disclosures: ACC Foundation: Consultant; Biosense / Webster: Consultant,

More information

ECG monitoring after ischemic stroke of TIA of unknown source with an insertable monitor? YES

ECG monitoring after ischemic stroke of TIA of unknown source with an insertable monitor? YES ECG monitoring after ischemic stroke of TIA of unknown source with an insertable monitor? YES Isabelle C Van Gelder University Medical Center Groningen The Netherlands ESC stroke council Prague January

More information

Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure

Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure HOT TOPIC Cardiology Journal 2010, Vol. 17, No. 6, pp. 543 548 Copyright 2010 Via Medica ISSN 1897 5593 Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart

More information

Atrial Fibrillation Ablation: in Whom and How

Atrial Fibrillation Ablation: in Whom and How Update on Consensus Statement on Management of Atrial Fibrillation: EHRA 2012 Atrial Fibrillation Ablation: in Whom and How Update of HRS/EHRA AF/ECAS Ablation Document 2012 Anne M Gillis MD FHRS Professor

More information

AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015

AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015 AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015 Disclosures Research grant: St. Jude medical Speaking: Boehringer-Ingelheim Consulting: Arca Biopharma Learning

More information

«Aσθενής με ασυμπτωματικό WPW και παροξυσμική κολπική μαρμαρυγή» Χάρης Κοσσυβάκης Επιμελητής A Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.

«Aσθενής με ασυμπτωματικό WPW και παροξυσμική κολπική μαρμαρυγή» Χάρης Κοσσυβάκης Επιμελητής A Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. «Aσθενής με ασυμπτωματικό WPW και παροξυσμική κολπική μαρμαρυγή» Χάρης Κοσσυβάκης Επιμελητής A Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ» the primary mechanism of SCD in patients with WPW is the rapid conduction

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Morillo CA, Verma A, Connolly SJ, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2): a randomzied clinical

More information

Cryptogenic Stroke: The role of silent Atrial Fibrillation

Cryptogenic Stroke: The role of silent Atrial Fibrillation Cryptogenic Stroke: The role of silent Atrial Fibrillation PD Dr. med. Martin A. Ritter Westfälische Wilhelms-Universität Münster Germany ritterm@uni-muenster.de 1 Turin, 25.10.2014 Agenda 1. What is a

More information

How to treat Cardiac Resynchronization Therapy complications? C. Leclercq Departement of Cardiology Centre Cardio-Pneumologique Rennes, France

How to treat Cardiac Resynchronization Therapy complications? C. Leclercq Departement of Cardiology Centre Cardio-Pneumologique Rennes, France How to treat Cardiac Resynchronization Therapy complications? C. Leclercq Departement of Cardiology Centre Cardio-Pneumologique Rennes, France Presenter Disclosure Information Christophe Leclercq, MD,

More information

Summary, conclusions and future perspectives

Summary, conclusions and future perspectives Summary, conclusions and future perspectives Summary The general introduction (Chapter 1) of this thesis describes aspects of sudden cardiac death (SCD), ventricular arrhythmias, substrates for ventricular

More information

UTILITY OF THE IMPLANTABLE LOOP RECORDER

UTILITY OF THE IMPLANTABLE LOOP RECORDER UTILITY OF THE IMPLANTABLE LOOP RECORDER John Andriulli, DO Associate Professor of Medicine Director, Arrhythmia Device Program Cooper Medical School of Rowan University Contemporary Practices in Cardiology

More information

Long Standing Persistent AF ; CPVI is enough for it

Long Standing Persistent AF ; CPVI is enough for it Long Standing Persistent AF ; CPVI is enough for it Kee-Joon Choi, MD University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea Boston AF Symposium 2012 In a patient undergoing AF ablation

More information

Importance of CRT team for optimization of the results: a European point of view

Importance of CRT team for optimization of the results: a European point of view Importance of CRT team for optimization of the results: a European point of view Matteo Bertini, MD, PhD Arcispedale S. Anna Azienda Ospedaliero-Universitaria Cona-Ferrara No conflict of interest to declare

More information

ΑΣΥΜΠΤΩΜΑΤΙΚΗ ΚΟΛΠΙΚΗ ΜΑΡΜΑΡΥΓΗ

ΑΣΥΜΠΤΩΜΑΤΙΚΗ ΚΟΛΠΙΚΗ ΜΑΡΜΑΡΥΓΗ ΑΣΥΜΠΤΩΜΑΤΙΚΗ ΚΟΛΠΙΚΗ ΜΑΡΜΑΡΥΓΗ ΓΕΩΡΓΙΟΣ ΣΤΑΥΡΟΠΟΥΛΟΣ Β ΚΑΡΔΙΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ ΠΓΝΘ ΙΠΠΟΚΡΑΤΕΙΟ 9 Ο Βορειοελλα ATRIAL FIBRILATION Atrial fibrillation (AF) is the most common clinically significant heart

More information

How to Approach the Patient with CRT and Recurrent Heart Failure

How to Approach the Patient with CRT and Recurrent Heart Failure How to Approach the Patient with CRT and Recurrent Heart Failure Byron K. Lee MD Associate Professor of Medicine Electrophysiology and Arrhythmia Section UCSF Update in Electrocardiography and Arrhythmias

More information

Device based CRT optimization: is there a future? Lessons learned from published trials

Device based CRT optimization: is there a future? Lessons learned from published trials Device based CRT optimization: is there a future? Lessons learned from published trials C. Leclercq Department of Cardiology Centre Cardio-Pneumologique Rennes, France Presenter Disclosure Information

More information

Scompenso cardiaco e F A : ruolo della ablazione transcatetere. Prof. Fiorenzo Gaita

Scompenso cardiaco e F A : ruolo della ablazione transcatetere. Prof. Fiorenzo Gaita Scompenso cardiaco e F A : ruolo della ablazione transcatetere Prof. Fiorenzo Gaita Patients with atrial fibrillation (%) Prevalence of AF in HF Trials 60 50 30% NYHA III-IV NYHA IV 40 NYHA II-III 30 20

More information

La strategia diagnostica: il monitoraggio ecg prolungato. Michele Brignole

La strategia diagnostica: il monitoraggio ecg prolungato. Michele Brignole La strategia diagnostica: il monitoraggio ecg prolungato Michele Brignole ECG monitoring and syncope In-hospital monitoring Holter Monitoring External loop recorder Remote (at home) telemetry Implantable

More information

The Effect of Vagus Nerve Stimulation in Heart Failure: Primary Results of the INcrease Of VAgal TonE in chronic Heart Failure (INOVATE-HF) Trial

The Effect of Vagus Nerve Stimulation in Heart Failure: Primary Results of the INcrease Of VAgal TonE in chronic Heart Failure (INOVATE-HF) Trial The Effect of Vagus Nerve Stimulation in Heart Failure: Primary Results of the INcrease Of VAgal TonE in chronic Heart Failure (INOVATE-HF) Trial Michael R Gold, Brett J Berman, Martin Borggrefe, Sanja

More information

Atrial Fibrillation Ablation Recent Clinical Trials That Changed (or not) My Practice

Atrial Fibrillation Ablation Recent Clinical Trials That Changed (or not) My Practice Atrial Fibrillation Ablation Recent Clinical Trials That Changed (or not) My Practice Walid Saliba, MD, FHRS Director, Atrial Fibrillation Center Director EP laboratory Heart and Vascular Institute Cleveland

More information

Long-term Preservation of Left Ventricular Function and Heart Failure Incidence with Ablate and Pace Therapy Utilizing Biventricular Pacing

Long-term Preservation of Left Ventricular Function and Heart Failure Incidence with Ablate and Pace Therapy Utilizing Biventricular Pacing The Journal of Innovations in Cardiac Rhythm Management, 3 (2012), 976 981 HEART FAILURE RESEARCH ARTICLE Long-term Preservation of Left Ventricular Function and Heart Failure Incidence with Ablate and

More information

Fibrillation Atriale Paroxystique : ablation, résultats, complications

Fibrillation Atriale Paroxystique : ablation, résultats, complications Fibrillation Atriale Paroxystique : ablation, résultats, complications DIU Rythmologie Paris, le 27/01/16 sboveda@clinique-pasteur.com 1 A disease with bad consequences RR de patients en FA comparé avec

More information

Cardiac Resynchronization ICD Therapy: What is New?

Cardiac Resynchronization ICD Therapy: What is New? Cardiac Resynchronization ICD Therapy: What is New? Emile Daoud, MD Section Chief, Cardiac Electrophysiology Professor of Medicine The Ohio State University Normal Activation, Narrow QRS Synchrony Abnormal

More information

EP WIRE on Management Preexcitation syndromes

EP WIRE on Management Preexcitation syndromes EP WIRE on Management Preexcitation syndromes 1. Is your Institution: A University Hospital 70.7% 41 A Private Hospital 13.8% 8 Other Type of Hospital 15.5% 9 Institution name: 50 answered question 58

More information

Dipartimento di Scienze Cardiovascolari Università Campus Bio-Medico di Roma Dott. Vito Calabrese

Dipartimento di Scienze Cardiovascolari Università Campus Bio-Medico di Roma Dott. Vito Calabrese Dipartimento di Scienze Cardiovascolari Università Campus Bio-Medico di Roma Dott. Vito Calabrese Because the primary objective was cure symptomatic bradicardya due to syncope Because this is the common

More information

Atrial Fibrillation 2009

Atrial Fibrillation 2009 Atrial Fibrillation 2009 Michael Glikson, MD Director of Pacing & Electrophysiology Leviev Heart Center Sheba medical Center Sheba Medical Center Tel Hashomer The Leviev Heart Center Rhythm vs rate control

More information

Seek and Ye Shall Find: Surprising Findings When Using the ILR-LINQ

Seek and Ye Shall Find: Surprising Findings When Using the ILR-LINQ Seek and Ye Shall Find: Surprising Findings When Using the ILR-LINQ Suneet Mittal, MD, FACC, FHRS Director, Electrophysiology Laboratory Valley Health System www.arrhythmia.org; @drsuneet October 31, 2015

More information

Surgical Ablation for Lone AF: What have we learned after 30 years?

Surgical Ablation for Lone AF: What have we learned after 30 years? Surgical Ablation for Lone AF: What have we learned after 30 years? Ralph J. Damiano, Jr., MD Evarts A. Graham Professor of Surgery Chief of Cardiothoracic Surgery Vice Chairman, Department of Surgery

More information

Management of Atrial Fibrillation in Heart Failure

Management of Atrial Fibrillation in Heart Failure Management of Atrial Fibrillation in Heart Failure Hani Sabbour MD FACC FHRS FASE Clinical Assistant Professor of Cardiology Brown University, Warren Alpert School of Medicine Rhode Island, USA Consultant

More information

Diagnosing atrial fibrillation using implantable devices

Diagnosing atrial fibrillation using implantable devices Diagnosing atrial fibrillation using implantable devices Axel Brandes, MD, FESC Associate Professor of Electrophysiology and Cardiac Arrhythmias Dept. of Cardiology, Odense University Hospital, DK HRC

More information

AF Today: W. For the majority of patients with atrial. are the Options? Chris Case

AF Today: W. For the majority of patients with atrial. are the Options? Chris Case AF Today: W hat are the Options? Management strategies for patients with atrial fibrillation should depend on the individual patient. Treatment with medications seems adequate for most patients with atrial

More information

When does enhanced monitoring for atrial fibrillation add value?

When does enhanced monitoring for atrial fibrillation add value? When does enhanced monitoring for atrial fibrillation add value? Jonathan P. Piccini, MD, MHS, FHRS Associate Professor of Medicine Duke Clinical Research Institute Duke University Medical Center jonathan.piccini@duke.edu

More information

Rate vs. Rhythm Control in Atrial Fibrillation

Rate vs. Rhythm Control in Atrial Fibrillation Rate vs. Rhythm Control in Atrial Fibrillation Recent Perspectives Saeed Oraii MD Electrophysiologist Interventional Electrophysiologist Tehran Arrhythmia Clinic Delirium Cordis First described by Sir

More information

Recurrent refractory ventricular tachycardia in a patient with LVAD

Recurrent refractory ventricular tachycardia in a patient with LVAD Monster Cases Recurrent refractory ventricular tachycardia in a patient with LVAD Maurizio Lunati MD Director SC Cardiologia 3 Elettrofisiologia Chairman De Gasperis Cardio Center Department ASST G.O.M.

More information

Contemporary Strategies for Catheter Ablation of Atrial Fibrillation

Contemporary Strategies for Catheter Ablation of Atrial Fibrillation Contemporary Strategies for Catheter Ablation of Atrial Fibrillation Suneet Mittal, MD Director, Electrophysiology Medical Director, Snyder Center for Atrial Fibrillation The Arrhythmia Institute at The

More information

Cardiac resynchronization therapy for heart failure: state of the art

Cardiac resynchronization therapy for heart failure: state of the art Cardiac resynchronization therapy for heart failure: state of the art Béla Merkely MD, PhD, DSc, FESC, FACC Vice president of the European Society of Cardiology Honorary president of the Hungarian Society

More information

ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ. ΥΠΕΡ. Michalis Efremidis MD Second Department of Cardiology Evangelismos General Hospital

ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ. ΥΠΕΡ. Michalis Efremidis MD Second Department of Cardiology Evangelismos General Hospital ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ. ΥΠΕΡ. Michalis Efremidis MD Second Department of Cardiology Evangelismos General Hospital Rate control versus Rhythm control for Atrial Fibrillation AFFIRM N Engl J Med 2002;347:1825-33

More information

PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D.

PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D. PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D. Cardiologist and Electrophysiologist No conflict of interest related to this presentation Objectives 1. PVCs are benign. What is the Evidence?

More information

His Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017

His Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017 His Bundle Pacing: Where is it going? Kenneth A. Ellenbogen, M.D. Kontos Professor, VCU School of Medicine November 17, 2017 Conflicts Medtronic: Research, Honoraria, Consulting Boston Scientific: Research,

More information

Gender and cardiac resynchronization therapy. Chairs: David Heaven & Belinda Green. Gender and Cardiac Resynchronisation Therapy

Gender and cardiac resynchronization therapy. Chairs: David Heaven & Belinda Green. Gender and Cardiac Resynchronisation Therapy Electrophysiology Gender and cardiac resynchronization therapy Dean Boddington Chairs: David Heaven & Belinda Green Gender and Cardiac Resynchronisation Therapy Dean Boddington Tauranga Hospital 1 Disclosure/Warning

More information

Raphael Rosso MD, Yuval Levi Med. Eng., Sami Viskin MD Tel Aviv Sourasky Medical Center

Raphael Rosso MD, Yuval Levi Med. Eng., Sami Viskin MD Tel Aviv Sourasky Medical Center Radiofrequency Ablation of Atrial Fibrillation: Comparison of Success Rate of Circular Ablation vs Point-by-Point Ablation with Contact Force Assessment in Paroxysmal and Persistent Atrial Fibrillation

More information

Consensus document: Screening and Prevention of Atrial Fibrillation

Consensus document: Screening and Prevention of Atrial Fibrillation Consensus document: Screening and Prevention of Atrial Fibrillation Yong-Seog Oh, M.D.,Ph.D. Division of Cardiology, Department of Internal Medicine, Seoul St. Mary s Hospital, College of Medicine, The

More information

Targeting the late sodium channel: A new antiarrhythmic paradigm?

Targeting the late sodium channel: A new antiarrhythmic paradigm? Targeting the late sodium channel: A new antiarrhythmic paradigm? Wojciech Zareba, MD, PhD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY Disclosures: - Gilead Sciences:

More information

His Bundle Pacing in Bundle Branch Block May 11, 2017

His Bundle Pacing in Bundle Branch Block May 11, 2017 His Bundle Pacing in Bundle Branch Block May 11, 2017 Gopi Dandamudi, MD FHRS System Medical Director, IUH Cardiac EP Program Director, IUH Atrial Fibrillation Center Assistant Professor of Clinical Medicine

More information

Thoranis Chantrarat MD

Thoranis Chantrarat MD Device Therapy in Heart Failure Thoranis Chantrarat MD 1 Scope of presentation Natural history of heart failure Primary and secondary prevention ICD and its indication CRT and its indication 2 Severity

More information

Interesting EP Cases Catheter ablation to treat congestive heart failure (CHF)

Interesting EP Cases Catheter ablation to treat congestive heart failure (CHF) Interesting EP Cases Catheter ablation to treat congestive heart failure (CHF) Yiming WU, MD, PhD. Alaska heart and vascular institute. ywu@alaskaheart.com 907-561-3211 19 yo man transferred for out side

More information

Catheter Ablation for AF: Patients, Procedures, Outcomes

Catheter Ablation for AF: Patients, Procedures, Outcomes Catheter Ablation for AF: Patients, Procedures, Outcomes John Sapp Director Heart Rhythm, QEII Health Sciences Centre Professor of Medicine, Dalhousie University Atrial Fibrillation Atrial Fibrillation

More information